Unique ID issued by UMIN | UMIN000052975 |
---|---|
Receipt number | R000060436 |
Scientific Title | Development of care technology for pain and numbness as aftereffects of stroke |
Date of disclosure of the study information | 2023/12/01 |
Last modified on | 2023/12/05 13:24:45 |
Development of care techniques to reduce (alleviate) symptoms of pain and numbness as an aftereffect of stroke
Development of care techniques to reduce (alleviate) symptoms of pain and numbness as an aftereffect of stroke
Development of care technology for pain and numbness as aftereffects of stroke
Development of care technology for pain and numbness as aftereffects of stroke
Japan |
stroke
Nursing |
Others
NO
To verify the effectiveness of hand massage as a care technique for alleviating "pain and numbness" as an aftereffect of stroke.
Efficacy
1. Pain level: VAS (Visual Analogue Scale) [before and after the intervention, and upon waking and sleeping], SF-MPQ-2 (Short-Form McGill Pain Questionnaire-2) [before intervention, 1 month after, 2 months after].
2. Presence and amount of analgesic medication [daily].
Impact on life: SF-12 (MOS 12-Item Short-Form Health Survey) [before, one month after, and two months after the intervention], HADS (Hospital Anxiety and Depression Scale) [before, one month after, and two months after the intervention], SIAS (Stroke Impairment Assessment Set) [before intervention].
4. Relaxation effect: Heart rate variability [each time during intervention].
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Hand massage for 15 minutes at intervals of once a week for 2 months (8 times in total)
Not applicable |
Not applicable |
Male and Female
1.Patients with pain and numbness as a sequela of stroke
2.Pain and numbness intensity of 5/10 or higher on the Visual Analogue Scale (VAS)
3.Patients who can continuously participate in the care intervention for about 30 minutes once a week for 1-2 months.
4.Patients who are able to maintain a sitting position for about 30 minutes.
1.Patients who are judged by the attending physician, charge nurse, or principal investigator to be unsuitable as research participants at the time consent is obtained.
2.Patients who are judged by the attending physician, charge nurse, or principal investigator to be "unable to give effective informed consent due to language impairment, cognitive impairment, etc.".
3.Other patients who are judged by the principal investigator to be inappropriate as research participants.
30
1st name | KAZUE |
Middle name | |
Last name | TOKI |
Senri Kinran University
Faculty of Nursing
5650873
5-25-1 Fujishirodai, Suita, Osaka, Japan
0668727129
k-toki@cs.kinran.ac.jp
1st name | KAZUE |
Middle name | |
Last name | TOKI |
Senri Kinran University
Faculty of Nursing
5650873
5-25-1 Fujishirodai, Suita, Osaka, Japan
0668727129
k-toki@cs.kinran.ac.jp
Senri Kinran University
KAZUE TOKI
Ministry of Education, Culture, Sports, Science and Technology
Japanese Governmental office
Senri Kinran University, Human Subjects Research Ethics Review Committee
Fujishirodai, Suita, Osaka, 5650873 Japan
0668720673
collabo@cs.kinran.ac.jp
NO
2023 | Year | 12 | Month | 01 | Day |
Unpublished
Open public recruiting
2022 | Year | 12 | Month | 02 | Day |
2022 | Year | 12 | Month | 02 | Day |
2023 | Year | 12 | Month | 01 | Day |
2026 | Year | 03 | Month | 31 | Day |
2023 | Year | 12 | Month | 01 | Day |
2023 | Year | 12 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060436